_id
69207c9b1d3bbaa0018b1bbf
Ticker
KTTAW
Name
Pasithea Therapeutics Corp. Warrant
Exchange
NASDAQ
Address
1111 Lincoln Road, Miami Beach, FL, United States, 33139
Country
USA
Sector
Industry
Currency
USD
Website
https://www.pasithea.com
Description
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Last Close
0.0141
Volume
12444
Current Price
0.0123
Change
0.0004
Last Updated
2026-01-04T16:14:51.871Z
Image
https://logo.clearbit.com/www.pasithea.com
Ipo Date
2021-09-15T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
181541
Gross Profit
-181541
Operating Expenses
2928514
Operating Income
-3110055
Interest Expense
-
Pretax Income
-3037420
Net Income
-3037420
Eps
-0.40803600214938207
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-2855878
Operating Margin
-
Total Other Income Expense Net
72635
Cash
4122953
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
5529226
Property Plant Equipment
0
Total Assets
13630663
Payables
1337801
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1423982
Equity
12206682
Bs_currency_symbol
USD
Depreciation
181541
Change In Working Capital
-143227
Cash From Operations
-2890025
Capital Expenditures
5
Cash From Investing
-
Cash From Financing
-116145
Net Change In Cash
-2993500
Cf_currency_symbol
USD
PE
-
PB
0.0075009081091815125
ROE
-24.88325656390492
ROA
-22.28372897195096
FCF
-2890030
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
181541
Quarters > 0 > income Statement > gross Profit
-181541
Quarters > 0 > income Statement > operating Expenses
2928514
Quarters > 0 > income Statement > operating Income
-3110055
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3037420
Quarters > 0 > income Statement > net Income
-3037420
Quarters > 0 > income Statement > eps
-0.40803600214938207
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7444000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2855878
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
72635
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4122953
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5529226
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
13630663
Quarters > 0 > balance Sheet > payables
1337801
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1423982
Quarters > 0 > balance Sheet > equity
12206682
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3037420
Quarters > 0 > cash Flow > depreciation
181541
Quarters > 0 > cash Flow > change In Working Capital
-143227
Quarters > 0 > cash Flow > cash From Operations
-2890025
Quarters > 0 > cash Flow > capital Expenditures
5
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-116145
Quarters > 0 > cash Flow > net Change In Cash
-2993500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.40803600214938207
Quarters > 0 > ratios > PB
0.0075009081091815125
Quarters > 0 > ratios > ROE
-24.88325656390492
Quarters > 0 > ratios > ROA
-22.28372897195096
Quarters > 0 > ratios > FCF
-2890030
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
161745
Quarters > 1 > income Statement > gross Profit
-161745
Quarters > 1 > income Statement > operating Expenses
3810899
Quarters > 1 > income Statement > operating Income
-3810899
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3716157
Quarters > 1 > income Statement > net Income
-3716157
Quarters > 1 > income Statement > eps
-0.6587469694222079
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5641251
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3649154
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
94742
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
7217052
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
8636599
Quarters > 1 > balance Sheet > property Plant Equipment
113564
Quarters > 1 > balance Sheet > total Assets
17009142
Quarters > 1 > balance Sheet > payables
1581501
Quarters > 1 > balance Sheet > short Term Debt
155455
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1830697
Quarters > 1 > balance Sheet > equity
15178445
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3716157
Quarters > 1 > cash Flow > depreciation
161745
Quarters > 1 > cash Flow > change In Working Capital
-380309
Quarters > 1 > cash Flow > cash From Operations
-3868886
Quarters > 1 > cash Flow > capital Expenditures
4
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
5739029
Quarters > 1 > cash Flow > net Change In Cash
1875774
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6587469694222079
Quarters > 1 > ratios > PB
0.004571442417190957
Quarters > 1 > ratios > ROE
-24.483120635875412
Quarters > 1 > ratios > ROA
-21.847997976617513
Quarters > 1 > ratios > FCF
-3868890
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
161707
Quarters > 2 > income Statement > gross Profit
-161707
Quarters > 2 > income Statement > operating Expenses
3680179
Quarters > 2 > income Statement > operating Income
-3680179
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3563238
Quarters > 2 > income Statement > net Income
-3563238
Quarters > 2 > income Statement > eps
-3.2508863387958202
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1096082
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3517817
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
116941
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5341278
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
6124940
Quarters > 2 > balance Sheet > property Plant Equipment
117522
Quarters > 2 > balance Sheet > total Assets
14658982
Quarters > 2 > balance Sheet > payables
1325925
Quarters > 2 > balance Sheet > short Term Debt
268969
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1680199
Quarters > 2 > balance Sheet > equity
12978783
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3563238
Quarters > 2 > cash Flow > depreciation
161707
Quarters > 2 > cash Flow > change In Working Capital
316257
Quarters > 2 > cash Flow > cash From Operations
-3055757
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1474306
Quarters > 2 > cash Flow > net Change In Cash
-1581451
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-3.2508863387958202
Quarters > 2 > ratios > PB
0.001038757532196971
Quarters > 2 > ratios > ROE
-27.454330656425952
Quarters > 2 > ratios > ROA
-24.30754059183646
Quarters > 2 > ratios > FCF
-3055760
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
649028
Quarters > 3 > income Statement > cost Of Revenue
162258
Quarters > 3 > income Statement > gross Profit
-162258
Quarters > 3 > income Statement > operating Expenses
3097292
Quarters > 3 > income Statement > operating Income
-3259550
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3177661
Quarters > 3 > income Statement > net Income
-3177661
Quarters > 3 > income Statement > eps
-2.8991088257995297
Quarters > 3 > income Statement > dividends Per Share
359656000
Quarters > 3 > income Statement > shares Outstanding
1096082
Quarters > 3 > income Statement > income Tax Expense
-2
Quarters > 3 > income Statement > EBITDA
-3015403
Quarters > 3 > income Statement > operating Margin
-502.2202431944384
Quarters > 3 > income Statement > total Other Income Expense Net
81889
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6922729
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
7368315
Quarters > 3 > balance Sheet > property Plant Equipment
122343
Quarters > 3 > balance Sheet > total Assets
16064719
Quarters > 3 > balance Sheet > payables
1119871
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1282043
Quarters > 3 > balance Sheet > equity
14782676
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3177661
Quarters > 3 > cash Flow > depreciation
162258
Quarters > 3 > cash Flow > change In Working Capital
455390
Quarters > 3 > cash Flow > cash From Operations
-2443036
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-23550
Quarters > 3 > cash Flow > net Change In Cash
-2438440
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.8991088257995297
Quarters > 3 > ratios > PB
0.0009120005471269208
Quarters > 3 > ratios > ROE
-21.4958441895094
Quarters > 3 > ratios > ROA
-19.780370886039154
Quarters > 3 > ratios > FCF
-2443040
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-3.764151931811879
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
649029
Annuals > 0 > income Statement > gross Profit
-649029
Annuals > 0 > income Statement > operating Expenses
14249962
Annuals > 0 > income Statement > operating Income
-14249962
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-13904584
Annuals > 0 > income Statement > net Income
-13904584
Annuals > 0 > income Statement > eps
-12.685715119854171
Annuals > 0 > income Statement > dividends Per Share
359656000
Annuals > 0 > income Statement > shares Outstanding
1096082
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-13600933
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
345378
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6922729
Annuals > 0 > balance Sheet > short Term Investments
6915806271
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
7368315
Annuals > 0 > balance Sheet > property Plant Equipment
122343
Annuals > 0 > balance Sheet > total Assets
16064719
Annuals > 0 > balance Sheet > payables
1119871
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1282043
Annuals > 0 > balance Sheet > equity
14782676
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-13904584
Annuals > 0 > cash Flow > depreciation
649029
Annuals > 0 > cash Flow > change In Working Capital
-1519382
Annuals > 0 > cash Flow > cash From Operations
-13923438
Annuals > 0 > cash Flow > capital Expenditures
2
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
4517634
Annuals > 0 > cash Flow > net Change In Cash
-9408323
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-12.685715119854171
Annuals > 0 > ratios > PB
0.0010751225962065327
Annuals > 0 > ratios > ROE
-94.05999292685573
Annuals > 0 > ratios > ROA
-86.55354631475348
Annuals > 0 > ratios > FCF
-13923440
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
486559
Annuals > 1 > income Statement > cost Of Revenue
648454
Annuals > 1 > income Statement > gross Profit
-648454
Annuals > 1 > income Statement > operating Expenses
15979361
Annuals > 1 > income Statement > operating Income
-15979361
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-15507748
Annuals > 1 > income Statement > net Income
-15961658
Annuals > 1 > income Statement > eps
-13.012928420022828
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1226600
Annuals > 1 > income Statement > income Tax Expense
453910000
Annuals > 1 > income Statement > EBITDA
-15330907
Annuals > 1 > income Statement > operating Margin
-3284.1569059456306
Annuals > 1 > income Statement > total Other Income Expense Net
471613
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
16331052
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
40500
Annuals > 1 > balance Sheet > inventories
-40500
Annuals > 1 > balance Sheet > total Current Assets
16692154
Annuals > 1 > balance Sheet > property Plant Equipment
220479
Annuals > 1 > balance Sheet > total Assets
26116858
Annuals > 1 > balance Sheet > payables
2552360
Annuals > 1 > balance Sheet > short Term Debt
81680
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2718406
Annuals > 1 > balance Sheet > equity
23398452
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-15507748
Annuals > 1 > cash Flow > depreciation
648454
Annuals > 1 > cash Flow > change In Working Capital
1574185
Annuals > 1 > cash Flow > cash From Operations
-13425411
Annuals > 1 > cash Flow > capital Expenditures
34301
Annuals > 1 > cash Flow > cash From Investing
399006
Annuals > 1 > cash Flow > cash From Financing
-3726416
Annuals > 1 > cash Flow > net Change In Cash
-16756812
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-13.012928420022828
Annuals > 1 > ratios > PB
0.000760122934628325
Annuals > 1 > ratios > ROE
-68.21672647404196
Annuals > 1 > ratios > ROA
-61.11630273442541
Annuals > 1 > ratios > FCF
-13459712
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-27.663062444636726
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
486559
Annuals > 2 > income Statement > cost Of Revenue
5094
Annuals > 2 > income Statement > gross Profit
-5094
Annuals > 2 > income Statement > operating Expenses
12583877
Annuals > 2 > income Statement > operating Income
-12588971
Annuals > 2 > income Statement > interest Expense
102
Annuals > 2 > income Statement > pretax Income
-11727885
Annuals > 2 > income Statement > net Income
-13936452
Annuals > 2 > income Statement > eps
-11.040181757832087
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1262339
Annuals > 2 > income Statement > income Tax Expense
-879971
Annuals > 2 > income Statement > EBITDA
-11722791
Annuals > 2 > income Statement > operating Margin
-2587.347269293138
Annuals > 2 > income Statement > total Other Income Expense Net
861086
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
33087864
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
302132
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
34076693
Annuals > 2 > balance Sheet > property Plant Equipment
625625
Annuals > 2 > balance Sheet > total Assets
45180089
Annuals > 2 > balance Sheet > payables
1481393
Annuals > 2 > balance Sheet > short Term Debt
160362
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2681841
Annuals > 2 > balance Sheet > equity
42498248
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11727885
Annuals > 2 > cash Flow > depreciation
5094
Annuals > 2 > cash Flow > change In Working Capital
845349
Annuals > 2 > cash Flow > cash From Operations
-13691158
Annuals > 2 > cash Flow > capital Expenditures
107102
Annuals > 2 > cash Flow > cash From Investing
-2926597
Annuals > 2 > cash Flow > cash From Financing
-3206244
Annuals > 2 > cash Flow > net Change In Cash
-19878842
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-11.040181757832087
Annuals > 2 > ratios > PB
0.0004306981196024834
Annuals > 2 > ratios > ROE
-32.79300360805462
Annuals > 2 > ratios > ROA
-30.84644653975781
Annuals > 2 > ratios > FCF
-13798260
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-28.358862953927478
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
15062
Annuals > 3 > income Statement > cost Of Revenue
17275
Annuals > 3 > income Statement > gross Profit
-2213
Annuals > 3 > income Statement > operating Expenses
4505200
Annuals > 3 > income Statement > operating Income
-4507413
Annuals > 3 > income Statement > interest Expense
508
Annuals > 3 > income Statement > pretax Income
-2173521
Annuals > 3 > income Statement > net Income
-2173521
Annuals > 3 > income Statement > eps
-1.88933152993086
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1150418
Annuals > 3 > income Statement > income Tax Expense
508
Annuals > 3 > income Statement > EBITDA
-4506034
Annuals > 3 > income Statement > operating Margin
-29925.726995086974
Annuals > 3 > income Statement > total Other Income Expense Net
2333892
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
52966706
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
53300457
Annuals > 3 > balance Sheet > property Plant Equipment
20124
Annuals > 3 > balance Sheet > total Assets
53320581
Annuals > 3 > balance Sheet > payables
447280
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1900080
Annuals > 3 > balance Sheet > equity
51420501
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2173521
Annuals > 3 > cash Flow > depreciation
1379
Annuals > 3 > cash Flow > change In Working Capital
111234
Annuals > 3 > cash Flow > cash From Operations
-3174058
Annuals > 3 > cash Flow > capital Expenditures
21503
Annuals > 3 > cash Flow > cash From Investing
-21503
Annuals > 3 > cash Flow > cash From Financing
55929178
Annuals > 3 > cash Flow > net Change In Cash
52723056
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.88933152993086
Annuals > 3 > ratios > PB
0.00032440487112328996
Annuals > 3 > ratios > ROE
-4.226954148113026
Annuals > 3 > ratios > ROA
-4.076326550155183
Annuals > 3 > ratios > FCF
-3195561
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-212.16047005709734
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.40803600214938207
Valuation > metrics > PB
0.0075009081091815125
Valuation > final Score
70
Valuation > verdict
99.2% Undervalued
Profitability > metrics > ROE
-24.88325656390492
Profitability > metrics > ROA
-54.93390937538093
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11665594303185747
Risk > metrics > Interest Coverage
-17.131324982648643
Risk > final Score
-9
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.133070613641341
Liquidity > metrics > Quick Ratio
4.133070613641341
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-168
Prev Risks > 1
-264
Prev Risks > 2
-20
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:12:03.148Z
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADRI Stock Today: January 19 Canada push adds Vaughan Mills, Ottawa Meyka
Read more →AC.TO Stock Today: January 08 — Ottawa Lifts UAE, Saudi Flight Caps Meyka
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pasithea Therapeutics Corp. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.